wire - news in brief


Results 151 - 200 of 334.

Business / Economics - 05.02.2019

Business / Economics - 05.02.2019

Pharmacology - Health - 05.02.2019
Roche submits supplemental biologics license application to the US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes Kadcyla was granted Breakthrough Therapy Designation for this application Ro

Physics - Innovation / Technology - 04.02.2019
A new EPFL fund rewards nine open science ideas
A new EPFL fund rewards nine open science ideas
The first call for proposal for the EPFL Open Science Fund attracted nearly 50 propositions. Nine projects were selected and will receive support to develop ideas fostering open and reproducible research on campus, and beyond. In September 2018, EPFL President Martin Vetterli announced the creation of the Open Science Fund to support the best ideas from everyone on campus with a total of CHF 3 Mio over the period 2019-2021.

Pharmacology - Health - 01.02.2019
CHMP recommends EU approval of Roche’s Tecentriq in combination with Avastin and chemotherapy as an initial treatment for lung cancer
Recommendation based on the Phase III IMpower150 study which showed that Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) and chemotherapy (paclitaxel and carboplatin) helped people

Pharmacology - Health - 01.02.2019
CHMP recommends EU approval of Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in a prospective intra-patient comparison First new class of medicine in nearly 20 years for people wit

Environment - Business / Economics - 01.02.2019
Solar energy for a circular economy
A sustainable alternative to the fossil-based, energy-intensive production of fuels and basic products of the chemical industry, based solely on solar energy and universally available resources: This

Business / Economics - 31.01.2019
The corporate governance index, or how to measure the impact of certain corporate governance issues
The corporate governance index, or how to measure the impact of certain corporate governance issues
Although it is widely accepted that governance rules play a major role in the smooth running of businesses and contribute to market equilibrium, how can we measure businesses' degree of responsibility in this area?

Life Sciences - Environment - 30.01.2019
Urban biodiversity: Remarkable diversity of small animals in Basel gardens
Urban biodiversity: Remarkable diversity of small animals in Basel gardens
Gardens in urban areas can harbor a remarkable diversity of species. This has been found by researchers from the University of Basel in a field study carried out with the support of private garden owners from the Basel region. Furthermore, the research team shows that nature-friendly garden management and design can largely compensate for the negative effects of urbanization on biodiversity.

Computer Science / Telecom - Innovation / Technology - 30.01.2019
Using artificial intelligence to save bees
A beekeeper teamed up with the Signal Processing Laboratory 5 and a group of EPFL students to develop an app that counts the number of Varroa mites in beehives.

Pharmacology - Health - 30.01.2019
Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) - other company programmes in AD continue
At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared to 77.0% treated with Her

Architecture - 29.01.2019

Innovation / Technology - Health - 29.01.2019
Implants from the 3D printer
3D printing is finding its way into industrial manufacturing. This technology and the increasing digitalization of design and manufacturing processes - keyword "Industry 4.0" - will also play a central role in medical technology in the future. A new technology transfer centre in the canton of Solothurn will help to transfer know-how from science to industry - and at the same time accelerate research.

Life Sciences - Chemistry - 28.01.2019
How do mRNAs deal with stress?
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.

Materials Science - Chemistry - 25.01.2019

Environment - 24.01.2019
Eawag at the 2019 World Economic Forum
Eawag at the 2019 World Economic Forum
A walk-through exhibition introduces people to innovative projects from various institutes.

Event - 24.01.2019

Innovation / Technology - Astronomy / Space Science - 23.01.2019

Pharmacology - Life Sciences - 22.01.2019

Environment - Chemistry - 22.01.2019
More energy-efficient cruise ships
More energy-efficient cruise ships
An EPFL researcher has developed a system based on fuel cells to reduce the carbon footprint and energy consumption of cruise ships, which are increasingly popular among vacation goers around the world.

Health - Life Sciences - 22.01.2019

Administration - Business / Economics - 21.01.2019

Life Sciences - 21.01.2019
Octopus's Garden: The Stunning Life of Macroalgae
Octopus’s Garden: The Stunning Life of Macroalgae
The Botanical Garden of the University of Zurich is displaying large-format pictures of macroalgae taken by photographer Josh Westrich, bringing these maritime organisms into the tropical setting of UZH's greenhouses.

Pharmacology - Health - 17.01.2019
FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Tecentriq (atezolizumab) in combination with Abra

Environment - 15.01.2019
Carbon cycles as a yardstick for climate change
Carbon cycles as a yardstick for climate change
The study by 153 researchers from 40 countries found that climate factors such as temperature and humidity strongly influence the carbon cycles of river ecosystems.

Health - Materials Science - 15.01.2019
Ears from the 3D-printer
Ears from the 3D-printer
Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

Health - Life Sciences - 15.01.2019

Environment - Life Sciences - 15.01.2019
EPFL goes to New Zealand to study melting glaciers
Four EPFL researchers will explore New Zealand's glacier-fed streams for two months, marking the first step in a global journey that will take them across 15 countries by 2021.

Innovation / Technology - Business / Economics - 11.01.2019
EPFL drones draw crowds in Las Vegas
EPFL drones draw crowds in Las Vegas
This week, four EPFL-designed drones are being shown in the Swiss Pavilion at the Consumer Electronics Show in Las Vegas.

Innovation / Technology - 10.01.2019

Event - Business / Economics - 09.01.2019

Life Sciences - 09.01.2019
Change of Teeth Causes Yo-Yo Effect in Elephants' Weight
Change of Teeth Causes Yo-Yo Effect in Elephants’ Weight
The weight of elephants living in zoos fluctuates over the course of their adult lives in cycles lasting around a hundred months, researchers at the University of Zurich have found. The fluctuation is linked to the particular pattern of tooth change in elephants, which results in them having more or less chewing surface available.

Pharmacology - Health - 08.01.2019
Novartis investigational therapy crizanlizumab (SEG101) receives FDA Breakthrough Therapy designation for the prevention of vaso-occlusive crises in sickle cell disease
Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease   Sickle cell VOCs, which are triggered

Pharmacology - Health - 07.01.2019
Sandoz and Pear Therapeutics Announce US Launch of reSET-OTM to Help Treat Opioid Use Disorder
ReSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use Disorder Cleared by the FDA in December, reSET-O is available immediately As part of a broader f

Innovation / Technology - Careers / Employment - 07.01.2019
Eleven EPFL startups in Las Vegas
Eleven EPFL startups in Las Vegas
This week, eleven EPFL startups are in Las Vegas to tout their technologies at the Consumer Electronics Show, one of the largest events of its kind.

Innovation / Technology - Health - 04.01.2019

Life Sciences - Physics - 02.01.2019
Pushing the boundaries of the visible
Our cutting-edge technology platforms are key enablers of research at the FMI. One of the biggest of these, with the largest number of users, is the Facility for Advanced Imaging and Microscopy (FAIM). To find out more about the facility, and microscopy in general, we spoke to the joint heads of FAIM - Christel Genoud, who is responsible for Electron Microscopy, and Laurent Gelman, responsible for Light Microscopy.

Health - Pharmacology - 21.12.2018
Novartis receives European Commission (EC) approval for expanded indication for Kisqali (ribociclib)
Basel, December 21, 2018 - Novartis today announced that the European Commission (EC) approved an expanded indication for Kisqali  (ribociclib), the CDK4/6 inhibitor with the largest body of first-li